Kenneth Houchin, MD
Ophthalmology · Las Vegas, NVNPI 1720047699
Payments from drug & device makers
Across 64 payments — averaging $27.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$1K
- Argenx US, Inc.$279
- AstraZeneca$170
- Biohaven Pharmaceuticals, Inc.$125
- Genentech USA, Inc.$20
- Alcon$17
What the payments were for
- Food & beverage$1,77299%
- Education$151%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 39 | $1,175 |
| Argenx US, Inc. | 14 | $279 |
| AstraZeneca | 8 | $170 |
| Biohaven Pharmaceuticals, Inc. | 1 | $125 |
| Genentech USA, Inc. | 1 | $20 |
| Alcon | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TEPEZZA$254
- UPLIZNA$243
- NURTEC ODT$125
How this compares
$1,787 in reported general payments places this provider in the 45th percentile of 121 ophthalmology providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RhopressaNetarsudil Mesylate | 11 | $5,138 |
| Timolol Maleate | 239 | $3,828 |
| LumiganBimatoprost | 12 | $3,542 |
| Latanoprost | 393 | $2,985 |
| Acetazolamide | 19 | $2,003 |
| Pyridostigmine Bromide | 15 | $1,026 |
| Prednisone | 85 | $944 |
| Prednisolone Acetate | 25 | $929 |
| Brimonidine Tartrate | 98 | $814 |
| Acetazolamide ErAcetazolamide | 21 | $708 |
| ClopidogrelClopidogrel Bisulfate | 48 | $323 |
| Gabapentin | 22 | $196 |
| Amitriptyline Hcl | 13 | $189 |
| Atenolol | 14 | $35 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Las Vegas
- Eva LiangLas Vegas$2.2M
- Matthew SwanicLas Vegas$433K
- Nelson LopezLas Vegas$193K
- Kent WellishLas Vegas$185K
- Allen ThachLas Vegas$173K
- Steven LeibowitzLas Vegas$157K
- Michael PernulaLas Vegas$149K
- Matthew PezdaLas Vegas$136K
- Mark DoubravaLas Vegas$66K
- Emil SteinLas Vegas$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.